papillomavirus infections

Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

---

Study Counts

Type	Study_count
Total_Studies	197
interventional	128
Observational	65
Registry	4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type	Study_Count
Biological	29
Biological|placebo	18
Behavioral	12
Drug	12
Device	10
Other	10
Drug|placebo	5
Other|Procedure	4
Procedure	4
Biological|Other	3
Diagnostic Test	3
Biological|Drug	2
Biological|Other|Procedure	2
Device|Drug	2
Dietary Supplement|placebo	2
Drug|Other|Procedure|Radiation	2
Drug|Procedure|Radiation	2
Biological|Drug|placebo	1
Combination Product	1
Device|placebo	1
Dietary Supplement|Other|placebo	1
Drug|Other|Radiation	1
Other|placebo	1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country	Study_Count
United States	40
NA	31
China	8
Czechia	4
France	4
Spain	4
Canada	3
Kenya	3
Costa Rica	2
United Kingdom	2
United States|Puerto Rico	2
Argentina|France	1
Austria|Belgium|Finland|Germany|Italy|Spain	1
Belgium	1
Belgium|Germany|Netherlands	1
Bolivia	1
Botswana	1
Colombia|Germany|Honduras|Panama|Taiwan	1
Congo, The Democratic Republic of the	1
Cuba	1
Denmark	1
Hong Kong	1
Italy	1
Japan	1
Kenya|Malawi|South Africa|Tanzania|Uganda|Zimbabwe	1
Madagascar	1
Peru	1
Switzerland	1
Taiwan	1
Thailand	1
Uganda	1
United States|Australia	1
United States|Belgium|Colombia|Czechia|France|Israel|Italy|Mexico|Peru|Spain|Taiwan	1
United States|Belgium|United Kingdom	1
United States|Canada	1
Vietnam	1

Sites per Study

Site_count	Study_Count
1	85
2	8
3	6
4	6
5	5
6	2
7	4
8	3
9	1
12	1
13	1
17	1
18	1
24	1
28	1
57	1
58	1

Phase

Phase	Study_Count
N/A	40
Phase 3	30
Phase 2	29
Phase 1	10
Phase 4	9
Phase 1/Phase 2	6
Early Phase 1	2
Phase 2/Phase 3	2

Number of Arms

Number_of_Arms	Count_of_Studies
1	35
2	59
3	14
4	9
5	5
6	1
10	1
NA	4

Enrollment Metrics by Phase

Measure	Early.Phase.1	N.A	Phase.1	Phase.1.Phase.2	Phase.2	Phase.2.Phase.3	Phase.3	Phase.4
Min.	1306	5.00	12.0	24.00000	7.0000	325.00	51.000	19.00
1st Qu.	2479	102.25	20.0	45.75000	50.0000	338.75	269.250	156.00
Median	3652	270.00	48.5	64.50000	84.0000	352.50	1226.500	300.00
Mean	3652	2768.70	53.5	73.83333	259.3103	352.50	2697.867	3283.25
3rd Qu.	4825	1058.75	90.0	69.00000	288.0000	366.25	3057.000	1312.50
Max.	5998	53414.00	98.0	180.00000	1499.0000	380.00	14840.000	22089.00

Trial Group Type

group_type	Group_Count
Experimental	168
Active Comparator	39
Placebo Comparator	35
Other	16
No Intervention	14
NA	4

Intervention Model

intervention_model	Study_Count
Parallel Assignment	73
Single Group Assignment	40
Sequential Assignment	6
Factorial Assignment	5
Crossover Assignment	2
NA	2

Primary Purpose

primary_purpose	Study_Count
Prevention	53
Treatment	44
Screening	12
Health Services Research	7
Diagnostic	6
Basic Science	3
Other	1
Supportive Care	1
NA	1

Observational Studies

Studies by Country

Country	Study_Count
United States	23
NA	9
France	5
Belgium	3
Thailand	3
Australia	2
Canada	2
China	2
Bahrain	1
Brazil	1
Costa Rica	1
Denmark	1
Egypt	1
Germany	1
Martinique	1
Netherlands	1
Spain	1
Sweden	1
Switzerland	1
Taiwan	1
Turkey	1
United Kingdom	1
United States|Japan|Korea, Republic of	1
Venezuela	1

Sites per Study

Site_count	Study_Count
1	49
2	4
3	5
4	3
5	1
7	1
24	1
161	1

Enrollment Metrics

Measure	Observational
Min	1.000
1st Qu	137.000
Median	400.000
Mean	6783.677
3rd Qu	1260.000
Max	189629.000

Observation Model

observational_model	Study_Count
Cohort	33
Ecologic or Community	10
NA	10
Case-Control	3
Case-Only	3
Case Control	3
Other	3

Time Perspective

time_perspective	Study_Count
Prospective	42
Cross-Sectional	8
Retrospective	8
Other	4
NA	3

Registries

Studies by Country

Country	Study_Count
China	2
Spain	1
United Kingdom	1

Sites per Study

Site_count	Study_Count
1	2
9	1
44	1

Enrollment Metrics

Measure	Registries
Min	151.00
1st Qu	217.75
Median	270.00
Mean	272.75
3rd Qu	325.00
Max	400.00

Registry Model

observational_model	Study_Count
Cohort	2
Case-Control	1
Case-Only	1

Time Perspective

time_perspective	Study_Count
Prospective	4

Follow-up

target_duration	Study_Count
3 Years	2
1 Year	1
32 Months	1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT04199689	Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)	https://ClinicalTrials.gov/show/NCT04199689	Recruiting	Merck Sharp & Dohme Corp.	2024-07-15
NCT04015336	E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer	https://ClinicalTrials.gov/show/NCT04015336	Recruiting	National Institutes of Health Clinical Center (CC)	2023-04-28
NCT04133610	HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs	https://ClinicalTrials.gov/show/NCT04133610	Completed	The Institute of Molecular and Translational Medicine, Czech Republic	2019-10-30
NCT03302858	A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRXâ„¢ Anorectal Wand	https://ClinicalTrials.gov/show/NCT03302858	Recruiting	Laser Surgery Care	2019-10-31
NCT03284866	HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV	https://ClinicalTrials.gov/show/NCT03284866	Active, not recruiting	AIDS Malignancy Consortium	2022-01-31
NCT03202992	Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection	https://ClinicalTrials.gov/show/NCT03202992	Completed	Antiva Biosciences	2019-02-04
NCT03180034	Scientific Evaluation of One or Two Doses of the Bivalent or Nonavalent Prophylactic HPV Vaccines	https://ClinicalTrials.gov/show/NCT03180034	Active, not recruiting	National Institutes of Health Clinical Center (CC)	2022-12-31
NCT03158220	Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)	https://ClinicalTrials.gov/show/NCT03158220	Completed	Merck Sharp & Dohme Corp.	2018-11-19
NCT03085381	A Phase I Study of Quadrivalent HPV Recombinant Vaccine	https://ClinicalTrials.gov/show/NCT03085381	Completed	Shanghai Bovax Biotechnology Co., Ltd.	2017-10-31
NCT03032575	Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection	https://ClinicalTrials.gov/show/NCT03032575	Recruiting	Thai Red Cross AIDS Research Centre	2020-12-31
NCT02862795	Human Papillomavirus Anal Infection	https://ClinicalTrials.gov/show/NCT02862795	Completed	Centre Hospitalier Universitaire de Besancon	2016-06-30
NCT02845739	PApillomavirus in REnal Transplant Patient	https://ClinicalTrials.gov/show/NCT02845739	Completed	Centre Hospitalier Universitaire de Besancon	2017-11-10
NCT02827838	Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer	https://ClinicalTrials.gov/show/NCT02827838	Recruiting	Wake Forest University Health Sciences	2020-08-31
NCT02816879	Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men	https://ClinicalTrials.gov/show/NCT02816879	Active, not recruiting	Jonsson Comprehensive Cancer Center	2020-07-31
NCT02811367	The HPV Self-test as a Test of Cure in Madagascar	https://ClinicalTrials.gov/show/NCT02811367	Completed	University Hospital, Geneva	2016-09-30
NCT02785289	A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection	https://ClinicalTrials.gov/show/NCT02785289	Completed	University Hospital, Geneva	2016-09-30
NCT02774538	Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort	https://ClinicalTrials.gov/show/NCT02774538	Recruiting	Institut de Cancérologie de Lorraine	2021-05-31
NCT02733068	A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.	https://ClinicalTrials.gov/show/NCT02733068	Active, not recruiting	Shanghai Zerun Biotechnology Co.,Ltd	2018-12-31
NCT02632344	Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement	https://ClinicalTrials.gov/show/NCT02632344	Active, not recruiting	Massachusetts General Hospital	2020-10-31
NCT02592902	Recurrent Respiratory Papillomatosis and Extraesophageal Reflux	https://ClinicalTrials.gov/show/NCT02592902	Completed	University Hospital Ostrava	2018-08-31
NCT02576054	Safety and Tolerability Study of V501 in Japanese Boys (V501-200)	https://ClinicalTrials.gov/show/NCT02576054	Completed	Merck Sharp & Dohme Corp.	2018-08-08
NCT02558803	HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3	https://ClinicalTrials.gov/show/NCT02558803	Completed	Regenstrief Institute, Inc.	2016-05-31
NCT02858310	E7 TCR T Cells for Human Papillomavirus-Associated Cancers	https://ClinicalTrials.gov/show/NCT02858310	Recruiting	National Institutes of Health Clinical Center (CC)	2020-12-31
NCT03391921	Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)	https://ClinicalTrials.gov/show/NCT03391921	Recruiting	Centre Hospitalier Universitaire Saint Pierre	2020-01-08
NCT02551887	HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts	https://ClinicalTrials.gov/show/NCT02551887	Completed	Regenstrief Institute, Inc.	2015-04-30
NCT02546752	Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine	https://ClinicalTrials.gov/show/NCT02546752	Completed	Regenstrief Institute, Inc.	2016-05-31
NCT02535104	Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)	https://ClinicalTrials.gov/show/NCT02535104	Completed	Tamir Biotechnology, Inc.	2016-09-30
NCT02464358	An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women	https://ClinicalTrials.gov/show/NCT02464358	Completed	University of Connecticut	2012-10-31
NCT02460237	HPV Self-Test Intervention in Ohio Appalachia	https://ClinicalTrials.gov/show/NCT02460237	Completed	Ohio State University Comprehensive Cancer Center	2016-06-14
NCT02405533	Phase II Evaluation of AHCC for the Eradication of HPV Infections	https://ClinicalTrials.gov/show/NCT02405533	Active, not recruiting	The University of Texas Health Science Center, Houston	2019-02-28
NCT02354144	Lubricant Investigation in Men to Inhibit Transmission of HPV Infection	https://ClinicalTrials.gov/show/NCT02354144	Recruiting	McGill University	2020-10-31
NCT02346227	Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix	https://ClinicalTrials.gov/show/NCT02346227	Completed	Universiteit Antwerpen	2018-08-31
NCT02304770	Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia	https://ClinicalTrials.gov/show/NCT02304770	Completed	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.	2017-01-31
NCT02287961	Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men	https://ClinicalTrials.gov/show/NCT02287961	Active, not recruiting	French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)	2021-06-30
NCT02263378	A New Supplement for the Immune Response to HPV Infection	https://ClinicalTrials.gov/show/NCT02263378	Completed	University of Messina	2016-03-31
NCT02258659	Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer	https://ClinicalTrials.gov/show/NCT02258659	Active, not recruiting	University of Chicago	2018-12-31
NCT02124252	Community-Driven Cervical Cancer Prevention in Western Kenya	https://ClinicalTrials.gov/show/NCT02124252	Completed	Duke University	2016-10-31
NCT02114385	A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020)	https://ClinicalTrials.gov/show/NCT02114385	Completed	Merck Sharp & Dohme Corp.	2015-04-22
NCT02067507	Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County	https://ClinicalTrials.gov/show/NCT02067507	Completed	University of California, Los Angeles	2019-10-31
NCT02065973	An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101	https://ClinicalTrials.gov/show/NCT02065973	Completed	PDS Biotechnology Corp.	2015-12-30
NCT02048020	Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer	https://ClinicalTrials.gov/show/NCT02048020	Completed	Jonsson Comprehensive Cancer Center	2017-01-09
NCT03929172	A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects	https://ClinicalTrials.gov/show/NCT03929172	Completed	2A Pharma AB	2020-05-29
NCT02009800	ICI-VPH: Impact of HPV Immunisation Schedules Against HPV	https://ClinicalTrials.gov/show/NCT02009800	Active, not recruiting	CHU de Quebec-Universite Laval	2021-12-31
NCT01984697	A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)	https://ClinicalTrials.gov/show/NCT01984697	Completed	Merck Sharp & Dohme Corp.	2015-06-19
NCT01946139	Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV	https://ClinicalTrials.gov/show/NCT01946139	Completed	AIDS Malignancy Consortium	2018-10-31
NCT01932697	Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer	https://ClinicalTrials.gov/show/NCT01932697	Active, not recruiting	Mayo Clinic	2016-10-20
NCT01924117	Genotypification and Predisposing Factors in Human Papilloma Virus Infection	https://ClinicalTrials.gov/show/NCT01924117	Completed	Materno-Perinatal Hospital of the State of Mexico	2011-05-31
NCT01901770	The Parents in Appalachia Receive Education Needed for Teen Project	https://ClinicalTrials.gov/show/NCT01901770	Active, not recruiting	Ohio State University Comprehensive Cancer Center	2020-12-31
NCT01898494	Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer	https://ClinicalTrials.gov/show/NCT01898494	Active, not recruiting	Eastern Cooperative Oncology Group	2020-02-29
NCT01862874	Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)	https://ClinicalTrials.gov/show/NCT01862874	Completed	Merck Sharp & Dohme Corp.	2017-08-30
NCT01824992	Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections	https://ClinicalTrials.gov/show/NCT01824992	Completed	Lee’s Pharmaceutical Limited	2012-03-31
NCT01824537	Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study	https://ClinicalTrials.gov/show/NCT01824537	Recruiting	McGill University	2020-09-30
NCT01693783	Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer	https://ClinicalTrials.gov/show/NCT01693783	Active, not recruiting	National Cancer Institute (NCI)	2020-12-31
NCT01588301	Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention	https://ClinicalTrials.gov/show/NCT01588301	Completed	University Hospital, Tours	2012-12-31
NCT01571141	Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection	https://ClinicalTrials.gov/show/NCT01571141	Completed	AGUNCO Obstetrics and Gynecology Centre	NA
NCT01550783	Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening	https://ClinicalTrials.gov/show/NCT01550783	Completed	University of Washington	2017-11-16
NCT01532102	Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts	https://ClinicalTrials.gov/show/NCT01532102	Completed	Vaxart	2013-05-06
NCT01492582	Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors	https://ClinicalTrials.gov/show/NCT01492582	Active, not recruiting	University of Alabama at Birmingham	2019-02-08
NCT01375868	Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis	https://ClinicalTrials.gov/show/NCT01375868	Completed	Institute of Hematology and Blood Transfusion, Czech Republic	2018-12-31
NCT04438291	Effects of a HPV Vaccination Health-promotion Programme on Improving Vaccine Acceptance and Uptake Among Female Adolescents	https://ClinicalTrials.gov/show/NCT04438291	Recruiting	Chinese University of Hong Kong	2022-01-31
NCT04436133	Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)	https://ClinicalTrials.gov/show/NCT04436133	Recruiting	National Vaccine and Serum Institute, China	2021-01-22
NCT04398433	INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)	https://ClinicalTrials.gov/show/NCT04398433	Recruiting	Inovio Pharmaceuticals	2023-07-31
NCT04333212	HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix	https://ClinicalTrials.gov/show/NCT04333212	Completed	Chang Gung Memorial Hospital	2013-12-30
NCT04278326	Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments	https://ClinicalTrials.gov/show/NCT04278326	Recruiting	Centre Hospitalier Régional d’Orléans	2024-04-30
NCT04270773	Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women	https://ClinicalTrials.gov/show/NCT04270773	Recruiting	University Hospital Virgen de las Nieves	2022-07-30
NCT04247282	Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection	https://ClinicalTrials.gov/show/NCT04247282	Recruiting	National Institutes of Health Clinical Center (CC)	2022-08-31
NCT04226313	Self-sampling for Non-attenders to Cervical Cancer Screening	https://ClinicalTrials.gov/show/NCT04226313	Recruiting	The Institute of Molecular and Translational Medicine, Czech Republic	2020-12-01
NCT04210336	Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV	https://ClinicalTrials.gov/show/NCT04210336	Recruiting	Procare Health Iberia S.L.	2020-08-31
NCT04199078	Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.	https://ClinicalTrials.gov/show/NCT04199078	Recruiting	Procare Health Iberia S.L.	2020-06-30
NCT04191967	Thermocoagulation for Treatment of Precancerous Cervical Lesions	https://ClinicalTrials.gov/show/NCT04191967	Recruiting	University of California, San Francisco	2020-12-31
NCT04124198	Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma	https://ClinicalTrials.gov/show/NCT04124198	Recruiting	Rigshospitalet, Denmark	2024-01-31
NCT04083196	A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years	https://ClinicalTrials.gov/show/NCT04083196	Recruiting	National Vaccine and Serum Institute, China	2021-03-12
NCT04072913	Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix	https://ClinicalTrials.gov/show/NCT04072913	Completed	University Hospital, Bordeaux	2011-01-31
NCT04002154	Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV	https://ClinicalTrials.gov/show/NCT04002154	Completed	Procare Health Iberia S.L.	2018-07-31
NCT04000503	Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)	https://ClinicalTrials.gov/show/NCT04000503	Recruiting	University of British Columbia	2021-12-31
NCT03998254	Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)	https://ClinicalTrials.gov/show/NCT03998254	Active, not recruiting	Merck Sharp & Dohme Corp.	2027-02-01
NCT03981822	A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts	https://ClinicalTrials.gov/show/NCT03981822	Recruiting	Verrica Pharmaceuticals Inc.	2020-08-12
NCT03903562	Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)	https://ClinicalTrials.gov/show/NCT03903562	Active, not recruiting	Merck Sharp & Dohme Corp.	2020-07-31
NCT03900572	A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine	https://ClinicalTrials.gov/show/NCT03900572	Recruiting	Shanghai Zerun Biotechnology Co.,Ltd	2020-04-30
NCT03898167	Prospective Evaluation of Self-Testing to Increase Screening	https://ClinicalTrials.gov/show/NCT03898167	Enrolling by invitation	Baylor College of Medicine	2023-02-28
NCT03726151	Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs	https://ClinicalTrials.gov/show/NCT03726151	Enrolling by invitation	University of California, Los Angeles	2022-10-31
NCT03346915	Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention	https://ClinicalTrials.gov/show/NCT03346915	Completed	Boston Medical Center	2019-04-19
NCT03707587	M7824 in People With Recurrent Respiratory Papillomatosis	https://ClinicalTrials.gov/show/NCT03707587	Active, not recruiting	National Institutes of Health Clinical Center (CC)	2020-07-07
NCT03675256	The KEN SHE Study on HPV-vaccine Efficacy	https://ClinicalTrials.gov/show/NCT03675256	Active, not recruiting	University of Washington	2022-11-15
NCT03610581	Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix	https://ClinicalTrials.gov/show/NCT03610581	Recruiting	Janssen Vaccines & Prevention B.V.	2020-08-09
NCT03584308	Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal	https://ClinicalTrials.gov/show/NCT03584308	Completed	Catalysis SL	2018-05-15
NCT03546842	Safety and Immunogenicity Study of V503 (GARDASILâ„¢9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)	https://ClinicalTrials.gov/show/NCT03546842	Completed	Merck Sharp & Dohme Corp.	2019-01-29
NCT03510091	Video-Assisted Counseling for HPV Vaccination	https://ClinicalTrials.gov/show/NCT03510091	Recruiting	Le Bonheur Children’s Hospital	2018-11-30
NCT03487549	Cantharidin and Occlusion in Verruca Epithelium	https://ClinicalTrials.gov/show/NCT03487549	Completed	Verrica Pharmaceuticals Inc.	2019-05-16
NCT03442062	Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination	https://ClinicalTrials.gov/show/NCT03442062	Completed	University of North Carolina, Chapel Hill	2020-04-30
NCT01254643	A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008).	https://ClinicalTrials.gov/show/NCT01254643	Completed	Merck Sharp & Dohme Corp.	2013-08-10
NCT01245764	GARDASILâ„¢ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)	https://ClinicalTrials.gov/show/NCT01245764	Completed	Merck Sharp & Dohme Corp.	2013-04-15
NCT01104181	Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test	https://ClinicalTrials.gov/show/NCT01104181	Completed	Laser Surgery Care	2010-12-31
NCT01073293	A Study of V503 Vaccine Given Concomitantly With REPEVAXâ„¢ in 11 to 15 Year Olds (V503-007)	https://ClinicalTrials.gov/show/NCT01073293	Completed	Merck Sharp & Dohme Corp.	2011-06-16
NCT01020747	Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)	https://ClinicalTrials.gov/show/NCT01020747	Completed	Massachusetts General Hospital	2011-03-31
NCT00988884	A Study of V503 Given Concomitantly With Menactraâ„¢ and Adacelâ„¢ in 11 to 15 Year Olds (V503-005)	https://ClinicalTrials.gov/show/NCT00988884	Completed	Merck Sharp & Dohme Corp.	2011-02-22
NCT00973856	Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands	https://ClinicalTrials.gov/show/NCT00973856	Completed	Akron General Medical Center	2011-12-31
NCT00973362	Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System	https://ClinicalTrials.gov/show/NCT00973362	Completed	Gen-Probe, Incorporated	2013-06-30
NCT00956553	Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls	https://ClinicalTrials.gov/show/NCT00956553	Completed	Public Health England	2012-09-30
NCT00943722	A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)	https://ClinicalTrials.gov/show/NCT00943722	Active, not recruiting	Merck Sharp & Dohme Corp.	2011-04-30
NCT00925288	Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers	https://ClinicalTrials.gov/show/NCT00925288	Completed	Johns Hopkins Bloomberg School of Public Health	2011-08-31
NCT04369339	Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology	https://ClinicalTrials.gov/show/NCT04369339	Completed	Bezmialem Vakif University	2019-10-01
NCT03345875	Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana	https://ClinicalTrials.gov/show/NCT03345875	Completed	Jhpiego	2018-06-30
NCT00834106	Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)	https://ClinicalTrials.gov/show/NCT00834106	Completed	Merck Sharp & Dohme Corp.	2012-05-11
NCT02631863	Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)	https://ClinicalTrials.gov/show/NCT02631863	Completed	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.	2018-11-24
NCT02859454	Avelumab for People With Recurrent Respiratory Papillomatosis	https://ClinicalTrials.gov/show/NCT02859454	Active, not recruiting	National Institutes of Health Clinical Center (CC)	2018-06-30
NCT00685412	Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3	https://ClinicalTrials.gov/show/NCT00685412	Completed	Inovio Pharmaceuticals	2011-01-31
NCT00635830	An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)	https://ClinicalTrials.gov/show/NCT00635830	Completed	Merck Sharp & Dohme Corp.	2008-04-30
NCT00572832	Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting	https://ClinicalTrials.gov/show/NCT00572832	Completed	University of Pittsburgh	2009-04-30
NCT00571701	Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis	https://ClinicalTrials.gov/show/NCT00571701	Completed	Northwell Health	2015-01-31
NCT00551187	A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)	https://ClinicalTrials.gov/show/NCT00551187	Completed	Merck Sharp & Dohme Corp.	2009-05-31
NCT00543543	Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)	https://ClinicalTrials.gov/show/NCT00543543	Completed	Merck Sharp & Dohme Corp.	2013-04-10
NCT00520598	Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)	https://ClinicalTrials.gov/show/NCT00520598	Completed	Merck Sharp & Dohme Corp.	2011-05-31
NCT00518180	A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents	https://ClinicalTrials.gov/show/NCT00518180	Completed	Novartis	2008-04-30
NCT00496626	An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)	https://ClinicalTrials.gov/show/NCT00496626	Completed	Merck Sharp & Dohme Corp.	2009-02-28
NCT00411749	V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)	https://ClinicalTrials.gov/show/NCT00411749	Completed	Merck Sharp & Dohme Corp.	2009-09-18
NCT00380367	Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)	https://ClinicalTrials.gov/show/NCT00380367	Completed	Merck Sharp & Dohme Corp.	2008-02-04
NCT00378560	V501 Efficacy Study in Women Aged 18 to 26 (V501-027)	https://ClinicalTrials.gov/show/NCT00378560	Completed	Merck Sharp & Dohme Corp.	2009-09-16
NCT00365716	Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)	https://ClinicalTrials.gov/show/NCT00365716	Completed	Merck Sharp & Dohme Corp.	2004-05-31
NCT00316706	Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals’ (GSK Bio) HPV-16/18 Vaccine	https://ClinicalTrials.gov/show/NCT00316706	Completed	GlaxoSmithKline	2009-01-31
NCT00303823	Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia	https://ClinicalTrials.gov/show/NCT00303823	Completed	National Cancer Institute (NCI)	2010-11-30
NCT00205374	Use of Cidofovir for Recurrent Respiratory Papillomatosis	https://ClinicalTrials.gov/show/NCT00205374	Completed	University of Wisconsin, Madison	2009-12-31
NCT00157950	Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)	https://ClinicalTrials.gov/show/NCT00157950	Completed	Merck Sharp & Dohme Corp.	2006-06-30
NCT00092547	A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)	https://ClinicalTrials.gov/show/NCT00092547	Completed	Merck Sharp & Dohme Corp.	2005-11-03
NCT00090220	A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)	https://ClinicalTrials.gov/show/NCT00090220	Completed	Merck Sharp & Dohme Corp.	2009-05-21
NCT00054041	Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia	https://ClinicalTrials.gov/show/NCT00054041	Completed	National Cancer Institute (NCI)	2007-01-31
NCT00038714	A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis	https://ClinicalTrials.gov/show/NCT00038714	Completed	Nventa Biopharmaceuticals Corporation	NA
NCT00000764	Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.	https://ClinicalTrials.gov/show/NCT00000764	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA

Observational Studiess

#If less then 500 studies

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT03265743	HPV Vaccination in Women With Cystic Fibrosis	https://ClinicalTrials.gov/show/NCT03265743	Completed	Hospices Civils de Lyon	2017-12-15
NCT03082950	HPV Infections, Cancer of the Vulva and Therapeutical Success	https://ClinicalTrials.gov/show/NCT03082950	Completed	University of Luebeck	2017-12-31
NCT03000933	Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)	https://ClinicalTrials.gov/show/NCT03000933	Active, not recruiting	The Alfred	2019-12-31
NCT02897427	HPV-related Oropharyngeal and Uncommon Cancers Screening	https://ClinicalTrials.gov/show/NCT02897427	Recruiting	M.D. Anderson Cancer Center	2027-03-28
NCT02897232	Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination	https://ClinicalTrials.gov/show/NCT02897232	Active, not recruiting	Louisiana State University Health Sciences Center Shreveport	2017-03-31
NCT02809352	Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer	https://ClinicalTrials.gov/show/NCT02809352	Completed	CHU de Reims	2014-12-31
NCT02714114	Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)	https://ClinicalTrials.gov/show/NCT02714114	Completed	Universiteit Antwerpen	2015-12-31
NCT02653118	Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)	https://ClinicalTrials.gov/show/NCT02653118	Active, not recruiting	Merck Sharp & Dohme Corp.	2024-01-01
NCT02634190	Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens	https://ClinicalTrials.gov/show/NCT02634190	Active, not recruiting	Hologic Deutschland GmbH	2023-04-30
NCT00786760	Natural History of HPV Infection in Men: The HIM Study	https://ClinicalTrials.gov/show/NCT00786760	Completed	H. Lee Moffitt Cancer Center and Research Institute	2012-12-31
NCT02376478	On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection	https://ClinicalTrials.gov/show/NCT02376478	Completed	Medical University of Vienna	2011-01-31
NCT02355262	CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers	https://ClinicalTrials.gov/show/NCT02355262	Active, not recruiting	OHSU Knight Cancer Institute	2020-06-30
NCT02188004	The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases	https://ClinicalTrials.gov/show/NCT02188004	Completed	Xiamen University	2016-05-31
NCT01295242	Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)	https://ClinicalTrials.gov/show/NCT01295242	Completed	University of Washington	2012-08-31
NCT01894425	Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation	https://ClinicalTrials.gov/show/NCT01894425	Completed	Centre Hospitalier Universitaire de NÄ«mes	2016-10-23
NCT01788852	HPV in Adolescents	https://ClinicalTrials.gov/show/NCT01788852	Completed	The HIV Netherlands Australia Thailand Research Collaboration	2012-12-31
NCT01717443	Genital HPV Infections Before and After Renal Transplantation	https://ClinicalTrials.gov/show/NCT01717443	Completed	University Medical Center Nijmegen	2015-10-31
NCT01702337	Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine	https://ClinicalTrials.gov/show/NCT01702337	Completed	GlaxoSmithKline	2010-02-28
NCT01694875	Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System	https://ClinicalTrials.gov/show/NCT01694875	Completed	Gen-Probe, Incorporated	2012-11-30
NCT01567813	Post-Licensure Study of the Safety of GARDASILâ„¢ in Males (V501-070)	https://ClinicalTrials.gov/show/NCT01567813	Completed	Merck Sharp & Dohme Corp.	2019-06-01
NCT01492842	Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV	https://ClinicalTrials.gov/show/NCT01492842	Completed	University of North Carolina, Chapel Hill	2012-06-30
NCT01446198	Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System	https://ClinicalTrials.gov/show/NCT01446198	Completed	Gen-Probe, Incorporated	2012-05-31
NCT01384370	APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results	https://ClinicalTrials.gov/show/NCT01384370	Completed	Gen-Probe, Incorporated	2011-08-31
NCT04391647	Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples	https://ClinicalTrials.gov/show/NCT04391647	Recruiting	Universiteit Antwerpen	2020-07-31
NCT04171505	Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.	https://ClinicalTrials.gov/show/NCT04171505	Recruiting	Hospital San Carlos, Madrid	2019-11-04
NCT04167501	Impact of HPV Vaccination on Cervical High Grade Lesions in France	https://ClinicalTrials.gov/show/NCT04167501	Recruiting	Centre Hospitalier Universitaire de Besancon	2020-08-31
NCT04155294	Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV	https://ClinicalTrials.gov/show/NCT04155294	Recruiting	University of Oxford	2021-03-31
NCT04117386	Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium	https://ClinicalTrials.gov/show/NCT04117386	Recruiting	Chulalongkorn University	2020-05-31
NCT04057924	Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN	https://ClinicalTrials.gov/show/NCT04057924	Recruiting	University Hospital, Bordeaux	2029-09-01
NCT03961178	A Cohort Study for the Following up of Conization	https://ClinicalTrials.gov/show/NCT03961178	Recruiting	Peking Union Medical College Hospital	2021-05-22
NCT03888599	Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination	https://ClinicalTrials.gov/show/NCT03888599	Completed	University Hospital, Geneva	2019-06-01
NCT03837028	The Human Papilloma Virus Effect on Sexual Life	https://ClinicalTrials.gov/show/NCT03837028	Completed	Bakirkoy Dr. Sadi Konuk Research and Training Hospital	2018-06-01
NCT03638427	Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood	https://ClinicalTrials.gov/show/NCT03638427	Enrolling by invitation	Stanford University	2020-10-01
NCT03542227	Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine	https://ClinicalTrials.gov/show/NCT03542227	Active, not recruiting	Universiteit Antwerpen	2020-12-15
NCT03474211	Prevalence of HPV Infection Using Self-sampling	https://ClinicalTrials.gov/show/NCT03474211	Completed	University Hospital, Geneva	2017-01-31
NCT01265212	Prevalence of Human Papillomavirus in Men Living in the Northern Plains	https://ClinicalTrials.gov/show/NCT01265212	Completed	Sanford Health	2013-09-30
NCT01226368	Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.	https://ClinicalTrials.gov/show/NCT01226368	Completed	University Hospital Center of Martinique	2011-01-31
NCT01205412	An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain	https://ClinicalTrials.gov/show/NCT01205412	Completed	GlaxoSmithKline	2011-11-30
NCT01158209	An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt	https://ClinicalTrials.gov/show/NCT01158209	Completed	GlaxoSmithKline	2011-08-31
NCT01101828	Self-collected Swabs for HPV Testing in 18-24 Year Old Women	https://ClinicalTrials.gov/show/NCT01101828	Completed	University of Washington	2011-01-31
NCT01086709	Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191	https://ClinicalTrials.gov/show/NCT01086709	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT01078220	Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASILâ„¢ (V501-031)	https://ClinicalTrials.gov/show/NCT01078220	Completed	Merck Sharp & Dohme Corp.	2010-12-13
NCT01077856	GARDASILâ„¢ Vaccine Impact in Population Study (V501-033)	https://ClinicalTrials.gov/show/NCT01077856	Completed	Merck Sharp & Dohme Corp.	2014-12-02
NCT01030562	Immunogenicity of Off-Schedule Dosing of HPV Vaccine	https://ClinicalTrials.gov/show/NCT01030562	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	2014-03-05
NCT00937547	Human Papillomavirus Infection and Virus Genotyping in Uterine Cervix Cancer in Venezuela	https://ClinicalTrials.gov/show/NCT00937547	Completed	Instituto Oncologico Luis Razetti	2011-07-31
NCT00933140	Anal HPV Infection and Abnormal Cytology in HIV-infected Women	https://ClinicalTrials.gov/show/NCT00933140	Completed	Boston Medical Center	2009-09-30
NCT00932009	Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men	https://ClinicalTrials.gov/show/NCT00932009	Completed	Danish Cancer Society	2009-08-31
NCT00931190	Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia	https://ClinicalTrials.gov/show/NCT00931190	Completed	Lund University	NA
NCT00919997	Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men	https://ClinicalTrials.gov/show/NCT00919997	Completed	AIDS Malignancy Consortium	2010-07-31
NCT00892866	CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells	https://ClinicalTrials.gov/show/NCT00892866	Recruiting	Gynecologic Oncology Group	2025-05-31
NCT00847340	Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population	https://ClinicalTrials.gov/show/NCT00847340	Completed	La Fundacion para la Investigacion y el Desarrollo	2010-09-30
NCT04297670	HPV Prevalence in 16-20 Year Old Males	https://ClinicalTrials.gov/show/NCT04297670	Recruiting	Laval University	2020-12-31
NCT00828555	Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting	https://ClinicalTrials.gov/show/NCT00828555	Completed	Duke University	2009-04-30
NCT00823511	The Human Papillomavirus (HPV) Transmission Pilot Study	https://ClinicalTrials.gov/show/NCT00823511	Completed	H. Lee Moffitt Cancer Center and Research Institute	2012-01-31
NCT02003508	Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination	https://ClinicalTrials.gov/show/NCT02003508	Completed	The Alfred	2017-12-29
NCT01539668	Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas	https://ClinicalTrials.gov/show/NCT01539668	Completed	Barretos Cancer Hospital	2012-12-31
NCT01792973	HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study	https://ClinicalTrials.gov/show/NCT01792973	Completed	Institut de Recherche pour le Developpement	2016-12-31
NCT00743392	HPV Infections in Older Women	https://ClinicalTrials.gov/show/NCT00743392	Completed	University of Washington	2011-05-31
NCT00711815	A Study to Identify Markers in Blood and Tissue of HPV Clearance	https://ClinicalTrials.gov/show/NCT00711815	Completed	University of Alabama at Birmingham	2010-11-30
NCT00550914	Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP	https://ClinicalTrials.gov/show/NCT00550914	Completed	Massachusetts Eye and Ear Infirmary	NA
NCT00549250	Human Papillomavirus 6/11 in the Lower Airway of Neonates	https://ClinicalTrials.gov/show/NCT00549250	Completed	National Taiwan University Hospital	2008-06-30
NCT00508170	Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection	https://ClinicalTrials.gov/show/NCT00508170	Completed	M.D. Anderson Cancer Center	2010-01-31
NCT00461877	High-Risk HPV Infections in Women Aged 25 to 65	https://ClinicalTrials.gov/show/NCT00461877	Completed	University of Washington	2008-12-31
NCT00194311	Human Papillomavirus (HPV) Infection in Pregnancy	https://ClinicalTrials.gov/show/NCT00194311	Completed	University of Pennsylvania	2007-08-31
NCT00188292	Screening for HIV-Associated Anal Cancer	https://ClinicalTrials.gov/show/NCT00188292	Completed	University Health Network, Toronto	2012-06-30

Registries

#If less then 500 registries

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT04199260	Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV.	https://ClinicalTrials.gov/show/NCT04199260	Recruiting	Procare Health Iberia S.L.	2019-12-31
NCT03895866	Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota	https://ClinicalTrials.gov/show/NCT03895866	Recruiting	Peking Union Medical College Hospital	2020-02-11
NCT03548740	Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection	https://ClinicalTrials.gov/show/NCT03548740	Recruiting	Peking Union Medical College Hospital	2020-01-20
NCT03465280	Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)	https://ClinicalTrials.gov/show/NCT03465280	Recruiting	Newcastle-upon-Tyne Hospitals NHS Trust	2020-08-31